Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-12-30

Clinical Trial Update: Evaluate the Safety and Explore Efficacy of Umbilical Cord Mesenchymal Stem Cells in Acute Ischemic Stroke [Phase 1]

View source ↗

Summary

This Phase 1 trial is evaluating the safety and potential efficacy of Umbilical Cord Mesenchymal Stem Cells in patients with acute ischemic stroke.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Umbilical Cord Mesenchymal Stem Cells

Snippet

Sponsor: Ever Supreme Bio Technology Co., Ltd. | Conditions: Acute Stroke | Phase 1 | Status: ACTIVE_NOT_RECRUITING